Human Formulations

Tadalafil 10mg + Dapoxetine 30mg Tablets (entertc coated)

Tadalafil 10mg + Dapoxetine 30mg Tablets (entertc coated) is a tablet formulated with Tadalafil 10mg + Dapoxetine 30mg (entertc coated). The listed active ingredient profile is Tadalafil; Dapoxetine, placing the product in the sexual health / urology cate

Therapeutic RangesCardiac Range Single Ingredient Tablet
Sterile injectable formulation

Product information

Product Line
Human Formulations
Category
Therapeutic Ranges, Cardiac Range
Dosage Form
Tablet
Product Type
Single Ingredient

Available strengths

Tadalafil 10mg + Dapoxetine 30mg (entertc coated)

Description

Tadalafil 10mg + Dapoxetine 30mg Tablets (entertc coated) is a tablet formulated with Tadalafil 10mg + Dapoxetine 30mg (entertc coated). The listed active ingredient profile is Tadalafil; Dapoxetine, placing the product in the sexual health / urology category. The formulation contains medicines used in selected sexual-health indications and should be presented only according to the approved product label. The source identifies the dosage form as tablet with not specified presentation. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.
WHO-GMP Sourced
Sterile Supply
Regulatory Documentation
Quality Assured